March 17, 2017 09:00 AM EDT

Heart attack while on Repatha? Amgen will give you your money back

John Carroll

Editor & Founder

Washington, DC —Amgen has overcome one of the toughest challenges in cardio research, outlining a clear health benefit for its PCSK9 cholesterol drug Repatha …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Heart attack while on Repatha? Amgen will give you your money back

John Carroll

Editor & Founder

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

Two GSK trials with long-acting drug in chronic rhinosinusitis hit primary endpoints

Pfizer details results from failed Phase 3 trial of Duchenne muscular dystrophy gene therapy

Novo Nordisk files 18 lawsuits against GLP-1 compounders in 44 days

Updated: Lundbeck makes $2.6B cash move for Longboard a month after starting Phase 3 in Dravet syndrome

Novartis used a PRV to speed Kisqali's latest indication, FDA says

Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies

Heart at­tack while on Repatha? Am­gen will give you your mon­ey back

Editor & Founder

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Heart attack while on Repatha? Amgen will give you your money back